• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Raimund Jakesz, Walter Jonat, +10 authors Manfred Kaufmann
  • Medicine
  • The Lancet
  • 2005 (First Publication: 1 August 2005)
  • BACKGROUND Tamoxifen has been the standard adjuvant treatment for postmenopausal women with hormone-responsive early breast cancer for more than 20 years. However, the third-generation aromataseContinue Reading
  • Martin Filipits, Margaretha Rudas, +24 authors Michael Gnant
  • Medicine
  • Clinical Cancer Research
  • 2011 (First Publication: 1 August 2011)
  • Purpose: According to current guidelines, molecular tests predicting the outcome of breast cancer patients can be used to assist in making treatment decisions after consideration of conventionalContinue Reading
  • José Baselga, Vladimir Semiglazov, +17 authors Hope S Rugo
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2009 (First Publication: 1 June 2009)
  • PURPOSE Cross-talk between the estrogen receptor (ER) and the phosphoinositide-3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathways is a mechanism of resistance to endocrine therapy, andContinue Reading
  • Michael Gnant, Brigitte Mlineritsch, +17 authors Richard Greil
  • Medicine
  • The Lancet. Oncology
  • 2011 (First Publication: 1 July 2011)
  • BACKGROUND Analysis of the Austrian Breast and Colorectal Cancer Study Group trial-12 (ABCSG-12) at 48 months' follow-up showed that addition of zoledronic acid to adjuvant endocrine therapyContinue Reading
  • Michael Gnant, Brigitte Mlineritsch, +17 authors Raimund Jakesz
  • Medicine
  • The Lancet. Oncology
  • 2008 (First Publication: 1 September 2008)
  • BACKGROUND The Austrian Breast and Colorectal Cancer Study Group trial-12 (ABCSG-12) bone substudy assesses zoledronic acid for preventing bone loss associated with adjuvant endocrine therapy andContinue Reading
  • Bernhard Holzner, Georg Kemmler, +6 authors Barbara Sperner-Unterweger
  • Medicine
  • Acta oncologica
  • 2004 (First Publication: 1 March 2004)
  • The aims of this study were to derive population-based reference values for the Functional Assessment of Cancer Therapy Scale–General (FACT-G) and to investigate the impact of sociodemographicContinue Reading
  • Rainer Porschen, Hendrik-Tobias Arkenau, +9 authors Hans-Joachim Schmoll
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2007 (First Publication: 20 September 2007)
  • PURPOSE To compare the use of capecitabine plus oxaliplatin (CAPOX) with infusional fluorouracil (FU)/folinic acid plus oxaliplatin (FUFOX) as first-line therapy for patients with metastaticContinue Reading
  • Jonas Bergh, Igor Bondarenko, +12 authors Carla Giorgetti
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2012 (First Publication: 20 March 2012)
  • PURPOSE To investigate whether sunitinib plus docetaxel improves clinical outcomes for patients with human epidermal growth factor receptor 2 (HER2)/neu-negative advanced breast cancer (ABC) versusContinue Reading